|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/68 | |
| A61K 39/395 | |||
| A61K 31/551 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2850104 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13790467.8 |
| Europos patento paraiškos padavimo data | 2013-05-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/041209 |
| Data | 2013-05-15 |
| (87) | Numeris | WO 2013/173496 |
| Data | 2013-11-21 |
| (30) | Numeris | Data | Šalis |
| 201261649110 P | 2012-05-18 | US | |
| 201313804227 | 2013-03-14 | US |
| (72) |
SUTHERLAND, May Kung, US
RYAN, Maureen, US
SUSSMAN, Django, US
BURKE, Patrick, US
JEFFREY, Scott, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER |
| CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER |